FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283268002> ?p ?o ?g. }

• W4283268002 endingPage "2520" @default.
• W4283268002 startingPage "2520" @default.
• W4283268002 abstract "Neratinib (NTB) is an irreversible inhibitor of pan-human epidermal growth factor receptor (HER-2) tyrosine kinase and is used in the treatment of breast cancer. It is a poorly aqueous soluble drug and exhibits extremely low oral bioavailability at higher pH, leading to a diminishing of the therapeutic effects in the GIT. The main objective of the research was to formulate an oral raft-forming in situ gelling system of NTB to improve gastric retention and drug release in a controlled manner and remain floating in the stomach for a prolonged time. In this study, NTB solubility was enhanced by polyethylene glycol (PEG)-based solid dispersions (SDs), and an in situ gelling system was developed and optimized by a two-factor at three-level (32) factorial design. It was analyzed to study the impact of two independent variables viz sodium alginate [A] and HPMC K4M [B] on the responses, such as floating lag time, percentage (%) water uptake at 2 h, and % drug release at 6 h and 12 h. Among various SDs prepared using PEG 6000, formulation 1:3 showed the highest drug solubility. FT-IR spectra revealed no interactions between the drug and the polymer. The percentage of drug content in NTB SDs ranged from 96.22 ± 1.67% to 97.70 ± 1.89%. The developed in situ gel formulations exhibited a pH value of approximately 7. An in vitro gelation study of the in situ gel formulation showed immediate gelation and was retained for a longer period. From the obtained results of 32 factorial designs, it was observed that all the selected factors had a significant effect on the chosen response, supporting the precision of design employed for optimization. Thus, the developed oral raft-forming in situ gelling system of NTB can be a promising and alternate approach to enhance retention in the stomach and to attain sustained release of drug by floating, thereby augmenting the therapeutic efficacy of NTB." @default.
• W4283268002 created "2022-06-23" @default.
• W4283268002 creator A5017938926 @default.
• W4283268002 creator A5019967714 @default.
• W4283268002 creator A5031644040 @default.
• W4283268002 creator A5035109980 @default.
• W4283268002 creator A5040757168 @default.
• W4283268002 creator A5054375548 @default.
• W4283268002 creator A5064682051 @default.
• W4283268002 creator A5072326258 @default.
• W4283268002 creator A5079787243 @default.
• W4283268002 creator A5091048061 @default.
• W4283268002 date "2022-06-21" @default.
• W4283268002 modified "2023-10-14" @default.
• W4283268002 title "Development and Characterization of Oral Raft Forming In Situ Gelling System of Neratinib Anticancer Drug Using 32 Factorial Design" @default.
• W4283268002 cites W1274128148 @default.
• W4283268002 cites W145668544 @default.
• W4283268002 cites W1725330208 @default.
• W4283268002 cites W1978675154 @default.
• W4283268002 cites W1998280683 @default.
• W4283268002 cites W2037541385 @default.
• W4283268002 cites W2076528453 @default.
• W4283268002 cites W2083652561 @default.
• W4283268002 cites W2088384449 @default.
• W4283268002 cites W2158066033 @default.
• W4283268002 cites W2260735419 @default.
• W4283268002 cites W2289027866 @default.
• W4283268002 cites W256971392 @default.
• W4283268002 cites W2593435879 @default.
• W4283268002 cites W2737370020 @default.
• W4283268002 cites W2893734681 @default.
• W4283268002 cites W2933855365 @default.
• W4283268002 cites W2944950683 @default.
• W4283268002 cites W2952166131 @default.
• W4283268002 cites W2999417355 @default.
• W4283268002 cites W3000069095 @default.
• W4283268002 cites W3026004378 @default.
• W4283268002 cites W3042247124 @default.
• W4283268002 cites W3048234195 @default.
• W4283268002 cites W3104544272 @default.
• W4283268002 cites W3128815686 @default.
• W4283268002 cites W3171509040 @default.
• W4283268002 cites W3194882821 @default.
• W4283268002 cites W3211884578 @default.
• W4283268002 cites W4200154441 @default.
• W4283268002 cites W4200261265 @default.
• W4283268002 cites W4207052079 @default.
• W4283268002 cites W4214718137 @default.
• W4283268002 cites W4285719527 @default.
• W4283268002 cites W4287102497 @default.
• W4283268002 doi "https://doi.org/10.3390/polym14132520" @default.
• W4283268002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35808569" @default.
• W4283268002 hasPublicationYear "2022" @default.
• W4283268002 type Work @default.
• W4283268002 citedByCount "6" @default.
• W4283268002 countsByYear W42832680022022 @default.
• W4283268002 countsByYear W42832680022023 @default.
• W4283268002 crossrefType "journal-article" @default.
• W4283268002 hasAuthorship W4283268002A5017938926 @default.
• W4283268002 hasAuthorship W4283268002A5019967714 @default.
• W4283268002 hasAuthorship W4283268002A5031644040 @default.
• W4283268002 hasAuthorship W4283268002A5035109980 @default.
• W4283268002 hasAuthorship W4283268002A5040757168 @default.
• W4283268002 hasAuthorship W4283268002A5054375548 @default.
• W4283268002 hasAuthorship W4283268002A5064682051 @default.
• W4283268002 hasAuthorship W4283268002A5072326258 @default.
• W4283268002 hasAuthorship W4283268002A5079787243 @default.
• W4283268002 hasAuthorship W4283268002A5091048061 @default.
• W4283268002 hasBestOaLocation W42832680021 @default.
• W4283268002 hasConcept C10138342 @default.
• W4283268002 hasConcept C105795698 @default.
• W4283268002 hasConcept C121608353 @default.
• W4283268002 hasConcept C126322002 @default.
• W4283268002 hasConcept C155574463 @default.
• W4283268002 hasConcept C162324750 @default.
• W4283268002 hasConcept C169222746 @default.
• W4283268002 hasConcept C178790620 @default.
• W4283268002 hasConcept C181389837 @default.
• W4283268002 hasConcept C185592680 @default.
• W4283268002 hasConcept C2776964284 @default.
• W4283268002 hasConcept C2779413316 @default.
• W4283268002 hasConcept C2779786085 @default.
• W4283268002 hasConcept C2780035454 @default.
• W4283268002 hasConcept C33923547 @default.
• W4283268002 hasConcept C43617362 @default.
• W4283268002 hasConcept C530470458 @default.
• W4283268002 hasConcept C54400483 @default.
• W4283268002 hasConcept C55493867 @default.
• W4283268002 hasConcept C71924100 @default.
• W4283268002 hasConcept C98274493 @default.
• W4283268002 hasConceptScore W4283268002C10138342 @default.
• W4283268002 hasConceptScore W4283268002C105795698 @default.
• W4283268002 hasConceptScore W4283268002C121608353 @default.
• W4283268002 hasConceptScore W4283268002C126322002 @default.
• W4283268002 hasConceptScore W4283268002C155574463 @default.
• W4283268002 hasConceptScore W4283268002C162324750 @default.
• W4283268002 hasConceptScore W4283268002C169222746 @default.
• W4283268002 hasConceptScore W4283268002C178790620 @default.

• next